Author/Authors :
Taher, Mohammad Division of Gastroenterology and Hepatology - Tehran University of Medical Sciences - Imam Khomeini Hospital Complex - Tehran - Iran , Miroliaee, Arash Division of Gastroenterology and Hepatology - Tehran University of Medical Sciences - Imam Khomeini Hospital Complex - Tehran - Iran , Ebrahimi Daryani, Nasser Division of Gastroenterology and Hepatology - Tehran University of Medical Sciences - Imam Khomeini Hospital Complex - Tehran - Iran , Alborzi Avanaki, Foroogh Division of Gastroenterology and Hepatology - Tehran University of Medical Sciences - Imam Khomeini Hospital Complex - Tehran - Iran , Aletaha, Najmeh Division of Gastroenterology and Hepatology - Tehran University of Medical Sciences - Imam Khomeini Hospital Complex - Tehran - Iran , Nasiri-Toosi, Mohsen Division of Gastroenterology and Hepatology - Tehran University of Medical Sciences - Imam Khomeini Hospital Complex - Tehran - Iran , Dashti, Habibollah Division of Gastroenterology and Hepatology - Tehran University of Medical Sciences - Imam Khomeini Hospital Complex - Tehran - Iran , Basirat, Vahid Division of Gastroenterology and Hepatology - Tehran University of Medical Sciences - Imam Khomeini Hospital Complex - Tehran - Iran , Jafarian, Ali Liver transplantation Center - Tehran University of Medical Sciences - Tehran - Iran
Abstract :
The coronavirus associated disease 2019 (COVID-19) caused by the SARS-CoV-2 virus has rapidly spread all around the world and became pandemic in March 2020. Data on liver transplantation and chronic liver disease during the pandemic has remained scarce, and there is little information on whether immunosuppressed patients are at higher risk of developing severe COVID-19 infection. This review provides information for health care providers who care for patients with liver transplantation and chronic liver diseases.
Keywords:
